About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Relation, Interpersonal ‐ The reciprocal interaction of two or…
- Mefacit ‐ A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory,…
- Octanes ‐ Eight-carbon saturated hydrocarbon group of the methane series.…
- Partial Dentures ‐ A denture replacing one or more (but not all) natural teeth.…
- Reporting, Mandatory ‐ Legal requirement for physicians and other professionals providing…
- AIDS Long-Term Survivor ‐ Persons who have experienced prolonged survival of HIV infection.…
- Combination Chemotherapies ‐ Drug therapy with two or more drugs given separately for a combined…
- Double-Masked Studies ‐ A method of studying a drug or procedure in which both the subjects…
- Nervous Mouse ‐ Mice which carry mutant genes for neurologic defects or…
- Avian Encephalomyelitis Virus ‐ A tentative species in the genus HEPATOVIRUS infecting primarily…